Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Radiosurgery and SBRT|October 24, 2022
Factors associated with the use of salvage whole brain radiation therapy versus salvage stereotactic radiosurgery after initial stereotactic radiosurgery for brain metastasesYash S Soni, Benjamin J Rich, Deukwoo Kwon, et al.
Journal of Radiosurgery and SBRT|August 1, 2024
Patient and physician attitudes towards salvage stereotactic radiosurgery or radiotherapy for brain metastasesBenjamin J Rich, Timoteo Almeida, Jared A Maas, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in GlioblastomaKarthik K Ramesh, Vicki Huang, Jeffrey Rosenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.
Neuro-Oncology Advances|April 6, 2022
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastomaKarthik Ramesh, Eric A Mellon, Saumya S Gurbani, et al.
The Lancet. Oncology|May 11, 2016
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysisMustafa Suker, Berend R Beumer, Eran Sadot, et al.
Journal of Neuro-Oncology|August 24, 2024
Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learningCameron A Rivera, Shovan Bhatia, Alexis A Morell, et al.
International Journal of Radiation Oncology, Biology, Physics|April 19, 2024
Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM)Matthew Gallitto, Geoffrey Sedor, Albert Lee, et al.
Journal of the National Cancer Institute|May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
Pageof 8